Immunological Effects of Aster yomena Callus-Derived Extracellular Vesicles as Potential Therapeutic Agents against Allergic Asthma
Open Access
Abstract
Plant-derived extracellular vesicles, (EVs), have recently gained attention as potential therapeutic candidates. However, the varying properties of plants that are dependent on their growth conditions, and the unsustainable production of plant-derived EVs hinder drug development. Herein, we analyzed the secondary metabolites of Aster yomena callus-derived EVs (AYC-EVs) obtained via plant tissue cultures and performed an immune functional assay to assess the potential therapeutic effects of AYC-EVs against inflammatory diseases. AYC-EVs, approximately 225 nm in size, were isolated using tangential flow filtration (TFF) and cushioned ultracentrifugation. Metabolomic analysis, using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS), revealed that AYC-EVs contained 17 major metabolites. AYC-EVs inhibited the phenotypic and functional maturation of LPS-treated dendritic cells (DCs). Furthermore, LPS-treated DCs exposed to AYC-EVs showed decreased immunostimulatory capacity during induction of CD4+ and CD8+ T-cell proliferation and activation. AYC-EVs inhibited T-cell reactions associated with the etiology of asthma in asthmatic mouse models and improved various symptoms of asthma. This regulatory effect of AYC-EVs resembled that of dexamethasone, which is currently used to treat inflammatory diseases. These results provide a foundation for the development of plant-derived therapeutic agents for the treatment of various inflammatory diseases, as well as providing an insight into the possible mechanisms of action of AYC-EVs.Keywords
Funding Information
- National Research Council of Science & Technology (NST) grant by the Korea government (MSIT, CRC21021)
- Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program (KGM5242221, KGM5282223)
This publication has 52 references indexed in Scilit:
- The Dendritic Cell Response to Classic, Emerging, and Homeostatic Danger Signals. Implications for AutoimmunityFrontiers in Immunology, 2013
- Functions of T cells in asthma: more than just TH2 cellsNature Reviews Immunology, 2010
- Combined forced oscillation and forced expiration measurements in mice for the assessment of airway hyperresponsivenessRespiratory Research, 2010
- Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunityJournal of Inflammation, 2010
- Emerging Roles of T Helper Subsets in the Pathogenesis of AsthmaImmunological Investigations, 2010
- Dendritic cells and cytokines in human inflammatory and autoimmune diseasesCytokine & Growth Factor Reviews, 2008
- Use of dendritic cells in drug selection, development and therapyExpert Opinion on Drug Discovery, 2008
- Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccinesGene Therapy, 2005
- Plant cell culture for production of paclitaxel and other taxanesJournal of Bioscience and Bioengineering, 2002
- TH1 and TH2 in Human DiseasesClinical Immunology and Immunopathology, 1996